<?xml version="1.0" encoding="UTF-8"?>
<mods xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.loc.gov/mods/v3" version="3.1" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-1.xsd">
  <titleInfo>
    <title>Safety pharmacology in pharmaceutical development</title>
    <subTitle>approval and post marketing surveillance</subTitle>
  </titleInfo>
  <name type="personal">
    <namePart>Gad, Shayne C.</namePart>
    <namePart type="date">1948-</namePart>
    <role>
      <roleTerm authority="marcrelator" type="text">creator</roleTerm>
    </role>
  </name>
  <typeOfResource>text</typeOfResource>
  <genre authority="marc">bibliography</genre>
  <genre authority="lcsh">Electronic books.</genre>
  <originInfo>
    <place>
      <placeTerm type="code" authority="marccountry">flu</placeTerm>
    </place>
    <place>
      <placeTerm type="text">Boca Raton, Fla</placeTerm>
    </place>
    <publisher>CRC Press</publisher>
    <dateIssued>2012</dateIssued>
    <edition>2nd ed.</edition>
    <issuance>monographic</issuance>
  </originInfo>
  <language>
    <languageTerm authority="iso639-2b" type="code">eng</languageTerm>
  </language>
  <physicalDescription>
    <form authority="marcform">electronic</form>
    <form authority="gmd">electronic resource</form>
    <internetMediaType>application/PDF</internetMediaType>
    <extent>xv, 197 p. : ill.</extent>
  </physicalDescription>
  <abstract>"This book covers the regulatory required evaluation and study of the potentially adverse pharmacological effects of new drugs, from the general regulatory requirements to the specific studies that must be done and how they are performed and interpreted. Based on more than 30 years of direct experience, the author describes tricks and practical insights for making studies work and understanding why they don't. The second edition includes current regulations (US FDA and international especially Europe and Japan) and updated test methods, interpretation, and science"--Provided by publisher.</abstract>
  <tableOfContents>ch. 1. Safety pharmacology : background, history, issues, and concerns -- ch. 2. Regulatory requirements : ICH, FDA, EMA, and Japan -- ch. 3. Principles of screening and study design -- ch. 4. Cardiovascular system -- ch. 5. Central nervous system -- ch. 6. Respiratory system -- ch. 7. Renal function -- ch. 8. The gastrointestinal system -- ch. 9. The immune system.</tableOfContents>
  <note type="statement of responsibility">Shayne C. Gad.</note>
  <note>Rev. ed. of: Safety pharmacology in pharmaceutical development and approval. c2004.</note>
  <note>Includes bibliographical references and index.</note>
  <note>Also available in print edition.</note>
  <note>Mode of access: World Wide Web.</note>
  <subject authority="lcsh">
    <topic>Drug development</topic>
  </subject>
  <subject authority="lcsh">
    <topic>Drug approval</topic>
  </subject>
  <subject authority="lcsh">
    <topic>Pharmacology</topic>
  </subject>
  <relatedItem>
    <titleInfo>
      <title>Safety pharmacology in pharmaceutical development and approval</title>
    </titleInfo>
    <name type="personal">
      <namePart>Gad, Shayne C.,</namePart>
      <namePart type="date">1948-</namePart>
    </name>
  </relatedItem>
  <relatedItem type="otherFormat"/>
  <identifier type="isbn">9781439845684 (ebook : PDF)</identifier>
  <identifier type="uri">http://marc.crcnetbase.com/isbn/9781439845684</identifier>
  <location>
    <url>http://marc.crcnetbase.com/isbn/9781439845684</url>
  </location>
  <recordInfo>
    <recordContentSource authority="marcorg">BD-DhSAU</recordContentSource>
    <recordCreationDate encoding="marc">120530</recordCreationDate>
    <recordChangeDate encoding="iso8601">20151012144305.0</recordChangeDate>
    <recordIdentifier source="BD-DhSAU">CRC0KE12014PDF</recordIdentifier>
  </recordInfo>
</mods>
